EXOZYMES INC. Increase (Decrease) in Prepaid Expense and Other Assets
EXOZYMES INC. (EXOZ) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$86.66 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- EXOZYMES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$46.32K.
- EXOZYMES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$40.34K.
- EXOZYMES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $184.17K, a 51.66% increase year-over-year.
- EXOZYMES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$88.70K, a 393.99% decline year-over-year.
- EXOZYMES INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $19.10K, a 80.72% decline from fiscal 2024.
- EXOZYMES INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $99.03K, a 39.48% decline from fiscal 2023.
- EXOZYMES INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $163.63K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$46.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$86.66K 10-Q · filed 2026-08-13 | $97.51K derived: sum of 3 quarters · filed 2026-08-13 | $8.81K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$40.34K 10-Q · filed 2026-05-14 | $143.82K derived: sum of 2 quarters · filed 2026-05-14 | $55.13K derived: sum of 3 quarters · filed 2026-05-14 | $30.34K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $184.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $95.47K derived: sum of 2 quarters · filed 2026-03-30 | $70.68K derived: sum of 3 quarters · filed 2026-08-13 | $19.10K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$88.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$113.49K derived: sum of 2 quarters · filed 2026-08-13 | -$165.07K 10-Q · filed 2025-11-13 | -$43.64K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$24.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$76.37K 10-Q · filed 2026-08-13 | $45.06K derived: sum of 3 quarters · filed 2026-08-13 | $75.23K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$51.58K 10-Q · filed 2026-05-14 | $69.85K derived: sum of 2 quarters · filed 2026-05-14 | $100.02K derived: sum of 3 quarters · filed 2026-05-14 | -$8.58K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $121.43K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $151.60K derived: sum of 2 quarters · filed 2026-03-30 | $43.00K derived: sum of 3 quarters · filed 2026-03-30 | $99.03K 10-K · filed 2026-03-30 |
| 2024-09-30 | $30.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$78.44K derived: sum of 2 quarters · filed 2025-11-13 | -$22.40K 10-Q · filed 2025-11-13 | $85.63K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$108.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$52.57K 10-Q · filed 2025-08-12 | $55.46K derived: sum of 3 quarters · filed 2025-08-12 | |
| 2024-03-31 | $56.03K 10-Q · filed 2025-05-12 | $164.06K derived: sum of 2 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $108.03K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $163.63K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $55.59K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |